6.2.6.5	  Recommendations for the management of persistent PSA after radical prostatectomy,
Recommendations,Strength rating
Offer a prostate-specific membrane antigen (PSMA) positron emission tomography/  computed tomography (PET/CT scan to men with a persistent prostate-specific antigen    > 0.2 ng/mL if the results will influence subsequent treatment decisions.,Weak
Treat men with no evidence of metastatic disease with salvage radiotherapy and additional   hormonal therapy.,Weak
